02nd February 2022 | Pharma Updates

CSIR's Osteoporosis Drug To Be Developed In USA

Central Drug Research Institute’s bone health drug will be the first drug of the prestigious institute to be used by patients in the United States of America.

Mankind Pharma inks agreement to purchase Panacea Biotec Pharma's domestic business

Panacea Biotec Pharma is a subsidiary of Sputnik V maker Panacea Biotec; its domestic business had a turnover of Rs 219 crore in FY2021.

Denovo secures US FDA Approval to Start Phase IIb Trial in Depression

The Phase IIb trial will examine the safety and efficacy of liafensine in patients with Treatment-resistant depression.

FDA Okays Vonvendi

Takeda’s Vonvendi is the first treatment approved by the US FDA for routine prophylaxis.

Alembic receives FDA nod to market Clarithromycin tablets In USA

Its new ANDA is therapeutically similar to AbbVie Inc’s Biaxin Filmtab Tablets, which are used to treat patients with infections caused by designated, susceptible bacteria.

Insulet gets FDA approval for Insulin Dispenser

Vabysmo is the fourth FDA-approved drug for “wet” age-related macular degeneration.

Applaud Medical bags US FDA designation for urinary stone device

Applaud Medical has won breakthrough device designation from the drug regulator for its acoustic enhancer technology to be used for the discontinuity of calcium-based urinary stones.

Latest Label of Axi-Cel Based Is Approved by Drug Regulator

With this all-new label, axi-cel is the first chimeric antigen receptor T-cell therapy with label information that helps doctors manage side effects.

FDA Clears VySpine's ClariVy Cervical IBF System

The cervical IBF System is made for use in anterior cervical discectomy with fusion surgical procedures.

FDA Approves Janssen's CABENUVA

CABENUVA offers virologically smothered grown-ups living with HIV an injectable treatment alternative administered around six times a year.